What is the alternative to Orgovyx?: Understanding Prostate Cancer Treatment Options
•
4 min read
The FDA approved Orgovyx (relugolix) in 2020, introducing the first oral gonadotropin-releasing hormone (GnRH) antagonist for advanced prostate cancer. For patients seeking what is the alternative to Orgovyx, several other effective androgen-deprivation therapies are available, including injectable GnRH agonists and different types of hormone-targeting agents. These alternatives vary in their mechanism of action, administration route, side effects, and cost, making the choice a personalized decision based on a patient's health and treatment goals.
